Results from a post-hoc exploratory subgroup analysis from the NIAGARA Phase III trial showed AstraZeneca’s (AZN) IMFINZI, ...

Vistagen Therapeutics, Inc.'s fasedienol shows promise in treating social anxiety; new results expected 2025. Click for my ...

Welcome to the Moderna fourth quarter 2024 conference call. At this time, all participants are in a listen-only mode. After ...

The co-founder of Oracle wants America to upload all national data, including highly sensitive genomic data, into an ...

Meta plans to work on its own humanoid robot hardware, with an initial focus on household chores. Its bigger ambition is to ...

The poverty alleviation relocation programme (2016–2020) was a crucial initiative in China's fight against poverty, which was led and subsidised by the government with voluntary participation from the ...

Perplexity's Deep Research tool matches $75,000/month enterprise AI capabilities, forcing OpenAI and Google to justify premium pricing.

GU ASCO annual meeting featured a urothelial carcinoma session and a discussant presentation by Dr. Elizabeth Plimack discussing two abstracts: “Adjuvant nivolumab vs placebo for high-risk ...

The scientific and technical information disclosed in this document has been reviewed and approved by Jonathan Victor Hill BSc Hons, FAUSIMM, a Qualified Person consistent with NI 43-101 and a ...

American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA between February 13 th and 15 th 2025, was host to the Panning for Gold: The Role of ctDNA as ...